Cargando…

The history of neuromyelitis optica

The discovery of a novel serum autoantibody (termed NMO-IgG or AQP4-Ab) in a subset of patients in 2004 has revived interest in neuromyelitis optica (NMO). While the history of classical multiple sclerosis has been extensively studied, only little is known about the history of NMO. In the present ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarius, Sven, Wildemann, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599417/
https://www.ncbi.nlm.nih.gov/pubmed/23320783
http://dx.doi.org/10.1186/1742-2094-10-8
_version_ 1782262958637711360
author Jarius, Sven
Wildemann, Brigitte
author_facet Jarius, Sven
Wildemann, Brigitte
author_sort Jarius, Sven
collection PubMed
description The discovery of a novel serum autoantibody (termed NMO-IgG or AQP4-Ab) in a subset of patients in 2004 has revived interest in neuromyelitis optica (NMO). While the history of classical multiple sclerosis has been extensively studied, only little is known about the history of NMO. In the present article, we provide a comprehensive review of the early history of this rare but intriguing syndrome. We trace the origins of the concept of NMO in the 19th century medical literature and follow its evolution throughout the 20th and into the 21st century. Finally, we discuss recent proposals to revise the concept of NMO and explain why there is indeed a need for a more systematic and descriptive nomenclature.
format Online
Article
Text
id pubmed-3599417
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35994172013-03-17 The history of neuromyelitis optica Jarius, Sven Wildemann, Brigitte J Neuroinflammation Review The discovery of a novel serum autoantibody (termed NMO-IgG or AQP4-Ab) in a subset of patients in 2004 has revived interest in neuromyelitis optica (NMO). While the history of classical multiple sclerosis has been extensively studied, only little is known about the history of NMO. In the present article, we provide a comprehensive review of the early history of this rare but intriguing syndrome. We trace the origins of the concept of NMO in the 19th century medical literature and follow its evolution throughout the 20th and into the 21st century. Finally, we discuss recent proposals to revise the concept of NMO and explain why there is indeed a need for a more systematic and descriptive nomenclature. BioMed Central 2013-01-15 /pmc/articles/PMC3599417/ /pubmed/23320783 http://dx.doi.org/10.1186/1742-2094-10-8 Text en Copyright ©2013 Jarius and Wildemann; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Jarius, Sven
Wildemann, Brigitte
The history of neuromyelitis optica
title The history of neuromyelitis optica
title_full The history of neuromyelitis optica
title_fullStr The history of neuromyelitis optica
title_full_unstemmed The history of neuromyelitis optica
title_short The history of neuromyelitis optica
title_sort history of neuromyelitis optica
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599417/
https://www.ncbi.nlm.nih.gov/pubmed/23320783
http://dx.doi.org/10.1186/1742-2094-10-8
work_keys_str_mv AT jariussven thehistoryofneuromyelitisoptica
AT wildemannbrigitte thehistoryofneuromyelitisoptica
AT jariussven historyofneuromyelitisoptica
AT wildemannbrigitte historyofneuromyelitisoptica